418
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Detection of Carbapenem-resistance in CRE by Comparative Assessment of RAPIDEC® CARBA NP and Xpert™Carba-R Assay

, ORCID Icon, , , , , & show all
Pages 1123-1131 | Received 17 Oct 2022, Accepted 02 Feb 2023, Published online: 22 Feb 2023

References

  • Gupta N, Limbago BM, Patel JB, et al. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53(1):60–67. doi:10.1093/cid/cir202
  • Codjoe FS, Donkor ES. carbapenem resistance: a review. Med Sci. 2017;6(1):1.
  • van Loon K, Voor AF, Vos MC. A systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2018;62(1). doi:10.1128/AAC.01730-17
  • Carvalhaes CG, Picao RC, Nicoletti AG, et al. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. J Antimicrob Chemother. 2010;65(2):249–251. doi:10.1093/jac/dkp431
  • Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18(9):1503–1507. doi:10.3201/eid1809.120355
  • Tato M, Ruiz-Garbajosa P, Traczewski M, et al. Multisite evaluation of cepheid Xpert Carba-R assay for detection of carbapenemase-producing organisms in rectal swabs. J Clin Microbiol. 2016;54(7):1814–1819. doi:10.1128/JCM.00341-16
  • Sharaf M, Hamouda HI, Shabana S, et al. Design of lipid-based nanocarrier for drug delivery has a double therapy for six common pathogens eradication. Colloids Surf a Physicochem Eng Asp. 2021;625:126662. doi:10.1016/j.colsurfa.2021.126662
  • Sharaf M, Arif M, Khan S, et al. Co-delivery of hesperidin and clarithromycin in a nanostructured lipid carrier for the eradication of Helicobacter pylori in vitro. Bioorg Chem. 2021;112:104896. doi:10.1016/j.bioorg.2021.104896
  • Zasowski EJ, Rybak JM, Rybak MJ. The β-Lactams Strike Back: ceftazidime-Avibactam. Pharmacotherapy. 2015;35(8):755–770. doi:10.1002/phar.1622
  • Balkhy HH, El-Saed A, Johani SM, et al. The epidemiology of the first described carbapenem-resistant Klebsiella pneumoniae outbreak in a tertiary care hospital in Saudi Arabia: how far do we go? Eur J Clin Microbiol Infect Dis. 2012;31(8):1901–1909. doi:10.1007/s10096-011-1519-0
  • CDC. Facility Guidance for Control of Carbapenem-Resistant Enterobacteriaceae (CRE) Update-CRE Toolkit. CDC; 2015.
  • Levy Hara G, Gould I, Endimiani A, et al. Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an international working group. J Chemother. 2013;25(3):129–140. doi:10.1179/1973947812Y.0000000062
  • Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791–1798. doi:10.3201/eid1710.110655
  • Alotaibi FE, Bukhari EE, Al-Mohizea MM, et al. Emergence of carbapenem-resistant Enterobacteriaceae isolated from patients in a university hospital in Saudi Arabia. Epidemiology, clinical profiles and outcomes. J Infect Public Health. 2017;10(5):667–673. doi:10.1016/j.jiph.2017.05.004
  • Cosgrove SE, Carmeli Y, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003;36(11):1433–1437. doi:10.1086/375081
  • Spyridopoulou K, Psichogiou M, Sypsa V, et al. Containing carbapenemase-producing Klebsiella pneumoniae in an endemic setting. Antimicrob Resist Infect Control. 2020;9(1):102. doi:10.1186/s13756-020-00766-x
  • Chen C-W, Tang H-J, Chen -C-C, et al. The microbiological characteristics of carbapenem-resistant Enterobacteriaceae carrying the mcr-1 gene. J Clin Med. 2019;8(2):261. doi:10.3390/jcm8020261
  • Zaidah AR, Mohammad NI, Suraiya S, et al. High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting. Antimicrob Resist Infect Control. 2017;6(1):42. doi:10.1186/s13756-017-0200-5
  • Renteria MI, Biedenbach DJ, Bouchillon SK, et al. In vitro activity of tigecycline and comparators against carbapenem-resistant Enterobacteriaceae in Africa-Middle East countries: TEST 2007–2012. J Glob Antimicrob Resist. 2014;2(3):179–182. doi:10.1016/j.jgar.2014.03.002
  • Endimiani A, Patel G, Hujer KM, et al. In vitro activity of fosfomycin against bla KPC -containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin. Antimicrob Agents Chemother. 2010;54(1):526–529. doi:10.1128/AAC.01235-09
  • Khan FA, Hellmark B, Ehricht R, et al. Related carbapenemase-producing Klebsiella isolates detected in both a hospital and associated aquatic environment in Sweden. Eur J Clin Microbiol Infect Dis. 2018;37(12):2241–2251. doi:10.1007/s10096-018-3365-9
  • Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785–796. doi:10.1016/S1473-3099(13)70190-7
  • Sheng WH, Badal RE, Hsueh PR. Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother. 2013;57(7):2981–2988. doi:10.1128/AAC.00971-12
  • Miao M, Wen H, Xu P, et al. Genetic Diversity of Carbapenem-Resistant Enterobacteriaceae (CRE) clinical isolates from a tertiary hospital in eastern China. Front Microbiol. 2018;9:3341. doi:10.3389/fmicb.2018.03341
  • Khan S, Sharaf M, Ahmed I, et al. Potential utility of nano-based treatment approaches to address the risk of Helicobacter pylori. Expert Rev Anti Infect Ther. 2022;20(3):407–424. doi:10.1080/14787210.2022.1990041
  • Perovic O, Ismail H, Quan V, et al. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018. Eur J Clin Microbiol Infect Dis. 2020;39(7):1287–1294. doi:10.1007/s10096-020-03845-4
  • Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed Res Int. 2014;2014:249856. doi:10.1155/2014/249856
  • Shibl A, Senok A, Memish Z. Infectious diseases in the Arabian Peninsula and Egypt. Clin Microbiol Infect. 2012;18(11):1068–1080. doi:10.1111/1469-0691.12010
  • Alizadeh N, Samadi Kafil ARM, Hasani A, et al. Evaluation of resistance mechanisms in carbapenem-resistant Enterobacteriaceae. Infect Drug Resist. 2020;2020:1377–1385. doi:10.2147/IDR.S244357
  • Song W, Yoo G, Hwang GY, et al. Evaluation of diagnostic performance of RAPIDEC CARBA NP test for carbapenemase-producing Enterobacteriaceae. Ann Clin Microbiol. 2016;19:59–64. doi:10.5145/ACM.2016.19.3.59
  • Khalifa HO, Okanda T, Abd El-Hafeez AA, et al. Comparative evaluation of five assays for detection of carbapenemases with a proposed scheme for their precise application. J Mol Diagn. 2020;22(9):1129–1138. doi:10.1016/j.jmoldx.2020.05.012
  • Cury AP, Almeida Junior JN, Costa SF, et al. Diagnostic performance of the Xpert Carba-R™ assay directly from rectal swabs for active surveillance of carbapenemase-producing organisms in the largest Brazilian University Hospital. J Microbiol Methods. 2020;171:105884. doi:10.1016/j.mimet.2020.105884